Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT04262921
What this trial is testing

French COVID Cohort

Who this might be right for
Coronavirus Infections
Institut National de la Santé Et de la Recherche Médicale, France 4,415
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Large-scale testing (Phase 3)Ended earlyNCT04425629
What this trial is testing

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Who this might be right for
COVID-19
Regeneron Pharmaceuticals 10,078
Not applicableStudy completedNCT04570202
What this trial is testing

Health cAre woRkers exposeD to COVID-19

Who this might be right for
DepressionBurnout, ProfessionalPost Traumatic Stress Disorder
University Hospital, Tours 900
Testing effectiveness (Phase 2)Study completedNCT04760730
What this trial is testing

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
R-Pharm 100
Not applicableUnknownNCT04388631
What this trial is testing

Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health.

Who this might be right for
Coronavirus Disease 2019
Tongji Hospital 200
Not applicableStudy completedNCT04390165
What this trial is testing

Malaysian COVID-19 Anosmia Study (Phase 1) - A Nationwide Multicentre Cross-Sectional Study

Who this might be right for
SARS-CoV InfectionCOVID-19Anosmia+1 more
Hospital Sultanah Bahiyah 498
Not applicableUnknownNCT04384042
What this trial is testing

Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study

Who this might be right for
SARS-CoV InfectionCOVID-19Anosmia+1 more
Hospital Sultanah Bahiyah 60
Not applicableStudy completedNCT04611230
What this trial is testing

Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois

Who this might be right for
Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
AbbVie 1,007
Large-scale testing (Phase 3)Study completedNCT04380519
What this trial is testing

Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19)

Who this might be right for
COVID-19
R-Pharm International, LLC 372
Testing effectiveness (Phase 2)WithdrawnNCT05545319
What this trial is testing

Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Coronavirus Disease 2019 (COVID-19)Immunocompromised+2 more
Pfizer
Post-approval studies (Phase 4)UnknownNCT04263402
What this trial is testing

The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia

Who this might be right for
2019-nCoV Severe Pneumonia
Tongji Hospital 100
Testing effectiveness (Phase 2)Study completedNCT04380701
What this trial is testing

A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-19 in Healthy and Immunocompromised Adults

Who this might be right for
Infections, RespiratoryVirus DiseasesInfection Viral+3 more
BioNTech SE 512
Not applicableUnknownNCT04273646
What this trial is testing

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Who this might be right for
2019 Novel Coronavirus PneumoniaCOVID-19
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 48
Not applicableStudy completedNCT04588363
What this trial is testing

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Multisystem Inflammatory Syndrome in Children (MIS-C)Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases (NIAID) 244
Not applicableStudy completedNCT04755972
What this trial is testing

Mucolytics in Patients on Invasive Mechanical Ventilation Due to Severe Acute Respiratory Syndrome Coronavirus 2

Who this might be right for
Corona Virus InfectionPneumonia, Ventilator-Associated
Clinical Hospital Center, Split 175
Early research (Phase 1)WithdrawnNCT06397144
What this trial is testing

A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer
Testing effectiveness (Phase 2)Ended earlyNCT04511650
What this trial is testing

Evaluation of the Safety and Efficacy of Razuprotafib in Hospitalized Subjects With Coronavirus Disease 2019

Who this might be right for
COVID-19Acute Respiratory Distress Syndrome (ARDS)
EyePoint Pharmaceuticals, Inc. 31
Large-scale testing (Phase 3)UnknownNCT04351152
What this trial is testing

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
Humanigen, Inc. 520
Early research (Phase 1)Study completedNCT05142306
What this trial is testing

A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults

Who this might be right for
SARS-CoV-2 Infection
Emergent BioSolutions 23
Next Page